Search for Clinical Trial Results

Sponsored By

Abnormalities, Multiple - 435 Studies Found

Status Study
Completed Study Name: Multicenter Vitamin E Trial in Aging Persons With Down Syndrome
Condition:
  • Alzheimer's Disease
  • Down Syndrome

Date: 2012-05-02
Interventions:
  • Drug: Alpha-Tocopherol 1,000 I
Completed Study Name: Heterotaxy Syndrome and Intestinal Rotation Abnormalities - A Prospective Study
Condition: Heterotaxy Syndrome
Date: 2012-05-02
Completed Study Name: A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome
Condition: Down Syndrome
Date: 2012-03-23
Completed Study Name: Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children
Condition: Down Syndrome
Date: 2012-04-11
Interventions: Drug: thyroid hormone and folinic acid thyroid hormone 25microg or placebo in tablets folinic acid 5 mg
Completed Study Name: Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors
Condition:
  • Carney Complex
  • Chondrosarcoma
  • Gastrointestinal Stromal Tum
    Date: 2012-03-20
    Interventions:
    • Other: Laboratory Biomarker Analysis

Completed Study Name: Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas
Condition:
  • Basal Cell Nevus Syndrome
  • Gorlin's Syndrome

Date: 2012-03-14
Interventions:
  • Drug: Vismodegib 150 mg per da
Terminated Study Name: Liraglutide Use in Prader-Willi Syndrome
Condition:
  • Diabetes Mellitus Type 2
  • Prader Willi Syndrome

Date: 2012-02-21
Interventions: Drug: Liraglutide Liraglutide 0.6 mg SQ daily for one week, increase to a maximum dose of 1.8 mg SQ dail
Active, not recruiting Study Name: Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa
Condition:
  • Retinitis Pigmentosa
  • Usher Syndrome Type 2
  • Usher Syndrome
    Date: 2012-01-19
    Interventions: Drug: NT-501 Study participants will undergo surgery to have an NT-501 Encapsulated Cell Therapy implant
Completed Study Name: The Intestinal Function in People With Prader-Willi Syndrome
Condition:
  • Prader-Willi Syndrome
  • Constipation
  • Incontinence

Date: 2012-01-30
Active, not recruiting Study Name: Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome
Condition:
  • Silver Russell Syndrome
  • Prader-Willi Syndrome

Date: 2012-01-25
Interventions:
  • Drug: Anastrozole Anastrozole

<<< Previous | Next >>>